Medications

Pfizer enters the lucrative weight-loss drug market with a massive $10 billion Metsera acquisition, targeting a $150-200 billion industry dominated by competitors.

Rite Aid has permanently closed all stores after filing for bankruptcy twice in two years, ending the pharmacy chain's 60-year operation in the U.S.

Costco is partnering with the healthcare company Novo Nordisk to give members access to GLP-1 medications at just $499 for a four-week supply.

President Donald Trump announces drug pricing deal with Pfizer offering Americans discounts on medications through new TrumpRX website.

Pharmaceutical giant Eli Lilly expanded its Virginia facility investment plans to $5 billion from original $2.1 billion amid the Trump administration tariff threats on drug imports.

President Donald Trump used the story of an overweight friend getting weight-loss medication at a much lower cost overseas to illustrate why he’s working to cut prescription drug prices.

AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ongoing $3.5 billion investment in American innovation.

Hims & Hers on Tuesday announced a collaboration with drugmaker Novo Nordisk to bundle Wegovy and a Hims & Hers membership on its telehealth platform.

Billionaire entrepreneur Mark Cuban backed President Donald Trump's executive order on prescription drugs and healthcare and offered his insights on reforms in the pharmaceutical industry.

Exiger warns the U.S. is overly reliant on foreign countries to make key components of crucial medications as the Trump administration weighs tariffs on pharmaceutical imports.

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA).

The DOJ has filed a lawsuit against CVS Health, accusing the drugstore giant of filling prescriptions for controlled substances that “lacked a legitimate medical purpose."

In 2023, about one independent pharmacy closed every day, and similar numbers are expected for this year according to the National Community Pharmacists Association.

The southern Kentucky city of Bowling Green has emerged as a major center for weight loss drugs like Ozempic, Wegovy and Mounjaro, according to Bloomberg.

The general public and professionals should be vigilant about falsified weight loss medications, the World Health Organization (WHO) said on Thursday.

Wegovy has been FDA-approved for heart disease prevention. The semaglutide, originally approved for weight loss, is now approved to reduce the risk of cardiovascular death, heart attack and stroke.

After Flovent, one of the most popular inhalers for treating childhood asthma, was discontinued in January, some parents are reporting challenges in obtaining the generic versions of the medication.

Glaxo Smith Kline (GSK) announced in May that Flovent HFA, a metered-dose inhaler, as well as Flovent Diskus, a dry powder inhaler, would be discontinued as of Dec. 31, 2023. Experts weigh in.

The FTC and Rite Aid announced a settlement banning Rite Aid from using AI-powered facial recognition technologies for 5 years after the pharmacy chain's prior system lacked safeguards.

A study by a professional society of pharmacists found OpenAI's ChatGPT provided inaccurate or incomplete responses to nearly three-fourths of the medication questions it was posed.